These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16641901)

  • 21. Tumor cell-specific inhibition of MYC function using small molecule inhibitors of the HUWE1 ubiquitin ligase.
    Peter S; Bultinck J; Myant K; Jaenicke LA; Walz S; Müller J; Gmachl M; Treu M; Boehmelt G; Ade CP; Schmitz W; Wiegering A; Otto C; Popov N; Sansom O; Kraut N; Eilers M
    EMBO Mol Med; 2014 Dec; 6(12):1525-41. PubMed ID: 25253726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p53 ubiquitination: Mdm2 and beyond.
    Brooks CL; Gu W
    Mol Cell; 2006 Feb; 21(3):307-15. PubMed ID: 16455486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mule determines the apoptotic response to HDAC inhibitors by targeted ubiquitination and destruction of HDAC2.
    Zhang J; Kan S; Huang B; Hao Z; Mak TW; Zhong Q
    Genes Dev; 2011 Dec; 25(24):2610-8. PubMed ID: 22016339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p19(ARF) is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumor suppression in vivo.
    Tolbert D; Lu X; Yin C; Tantama M; Van Dyke T
    Mol Cell Biol; 2002 Jan; 22(1):370-7. PubMed ID: 11739748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different requirements for the cytostatic and apoptotic effects of type I interferons. Induction of apoptosis requires ARF but not p53 in osteosarcoma cell lines.
    Sandoval R; Xue J; Pilkinton M; Salvi D; Kiyokawa H; Colamonici OR
    J Biol Chem; 2004 Jul; 279(31):32275-80. PubMed ID: 15169789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of p53 localization and transcription by the HECT domain E3 ligase WWP1.
    Laine A; Ronai Z
    Oncogene; 2007 Mar; 26(10):1477-83. PubMed ID: 16924229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ubiquitination of, and sumoylation by, the Arf tumor suppressor.
    den Besten W; Kuo ML; Tago K; Williams RT; Sherr CJ
    Isr Med Assoc J; 2006 Apr; 8(4):249-51. PubMed ID: 16671360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional significance and therapeutic implication of ring-type E3 ligases in colorectal cancer.
    Liu L; Wong CC; Gong B; Yu J
    Oncogene; 2018 Jan; 37(2):148-159. PubMed ID: 28925398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Janus Face of p53-Targeting Ubiquitin Ligases.
    Hao Q; Chen Y; Zhou X
    Cells; 2020 Jul; 9(7):. PubMed ID: 32660118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. JFK, a Kelch domain-containing F-box protein, links the SCF complex to p53 regulation.
    Sun L; Shi L; Li W; Yu W; Liang J; Zhang H; Yang X; Wang Y; Li R; Yao X; Yi X; Shang Y
    Proc Natl Acad Sci U S A; 2009 Jun; 106(25):10195-200. PubMed ID: 19509332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The ARF tumour suppressor.
    Gallagher SJ; Kefford RF; Rizos H
    Int J Biochem Cell Biol; 2006; 38(10):1637-41. PubMed ID: 16600663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug resistance to inhibitors of the human double minute-2 E3 ligase is mediated by point mutations of p53, but can be overcome with the p53 targeting agent RITA.
    Jones RJ; Bjorklund CC; Baladandayuthapani V; Kuhn DJ; Orlowski RZ
    Mol Cancer Ther; 2012 Oct; 11(10):2243-53. PubMed ID: 22933706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cells.
    Yang Y; Ludwig RL; Jensen JP; Pierre SA; Medaglia MV; Davydov IV; Safiran YJ; Oberoi P; Kenten JH; Phillips AC; Weissman AM; Vousden KH
    Cancer Cell; 2005 Jun; 7(6):547-59. PubMed ID: 15950904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A network of substrates of the E3 ubiquitin ligases MDM2 and HUWE1 control apoptosis independently of p53.
    Kurokawa M; Kim J; Geradts J; Matsuura K; Liu L; Ran X; Xia W; Ribar TJ; Henao R; Dewhirst MW; Kim WJ; Lucas JE; Wang S; Spector NL; Kornbluth S
    Sci Signal; 2013 May; 6(274):ra32. PubMed ID: 23652204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53.
    Honda R; Yasuda H
    EMBO J; 1999 Jan; 18(1):22-7. PubMed ID: 9878046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. E3 ubiquitin ligase Mule targets β-catenin under conditions of hyperactive Wnt signaling.
    Dominguez-Brauer C; Khatun R; Elia AJ; Thu KL; Ramachandran P; Baniasadi SP; Hao Z; Jones LD; Haight J; Sheng Y; Mak TW
    Proc Natl Acad Sci U S A; 2017 Feb; 114(7):E1148-E1157. PubMed ID: 28137882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BH3-ligand regulates access of MCL-1 to its E3 ligase.
    Warr MR; Acoca S; Liu Z; Germain M; Watson M; Blanchette M; Wing SS; Shore GC
    FEBS Lett; 2005 Oct; 579(25):5603-8. PubMed ID: 16213503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reactivating the ARF-p53 axis in AML cells by targeting ULF.
    Chen D; Yoon JB; Gu W
    Cell Cycle; 2010 Aug; 9(15):2946-51. PubMed ID: 20699639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel HECT-type E3 ubiquitin protein ligase NEDL1 enhances the p53-mediated apoptotic cell death in its catalytic activity-independent manner.
    Li Y; Ozaki T; Kikuchi H; Yamamoto H; Ohira M; Nakagawara A
    Oncogene; 2008 Jun; 27(26):3700-9. PubMed ID: 18223681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human tumor suppressor ARF impedes S-phase progression independent of p53.
    Yarbrough WG; Bessho M; Zanation A; Bisi JE; Xiong Y
    Cancer Res; 2002 Feb; 62(4):1171-7. PubMed ID: 11861400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.